SUBSCRIBE
SUBSCRIBE
News   Business

Neurogen Corporation Announces First Quarter 2008 Financial Results

May 8, 2008 | 
1 min read
BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug development company focused on improved drugs for psychiatric and neurologic disorders, today announced financial results for the quarter ended March 31, 2008.
Earnings
MORE ON THIS TOPIC
Paper cut saxophone musical background with flowing musical notes against a dynamic blue layered frame. Vector papercut depicts lively music and creativity for jazz enthusiasts or music concert promo
Deals
Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B
June 17, 2026
 · 
2 min read
 · 
Gabrielle Masson
Sorting trash or litter, recycling concept, clean and neat copy space background, vivid colors
Drug Development
Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program
June 17, 2026
 · 
2 min read
 · 
Tristan Manalac
Hands reach out to each other. Handshake between human and robot. Cooperation with artificial intelligence. Shaking hands. Make a deal. Successful agreement. Modern collage
Artificial intelligence
Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact
June 17, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
June 17, 2026
 · 
2 min read
 · 
Jef Akst